Description
Glifempa-XR Tablets (30’s)
Glifempa-XR is an extended-release oral antidiabetic medication combining Empagliflozin and Metformin XR (extended-release). It is designed for adults with type 2 diabetes mellitus who require dual therapy for effective and sustained blood glucose control.
Key Features:
-
Empagliflozin: An SGLT2 inhibitor that reduces blood sugar by increasing urinary glucose excretion.
-
Metformin XR: A long-acting biguanide that decreases hepatic glucose production and improves insulin sensitivity.
-
Extended-release formulation ensures steady drug levels with once-daily dosing.
-
May support weight management and has a low risk of hypoglycemia.
-
Shown to provide cardiovascular and renal protective benefits in appropriate patients.
Indications:
-
Treatment of type 2 diabetes mellitus in adults when diet, exercise, and single-agent therapy do not offer adequate control.
-
Used when both Empagliflozin and Metformin are indicated in combination.
Dosage & Administration:
-
Take once daily with the evening meal to reduce gastrointestinal side effects.
-
Dosage should be tailored to the patient’s blood glucose response and renal function.
-
Regular monitoring of blood glucose and kidney function is recommended.
Precautions:
-
Not for use in type 1 diabetes or diabetic ketoacidosis.
-
Use cautiously in patients with renal or hepatic impairment.
-
Watch for signs of lactic acidosis, dehydration, or genital/urinary infections.
-
Avoid alcohol and inform your doctor about all current medications.
Reviews
There are no reviews yet.